Therapeutic prospects for p73 and p63: Rising from the shadow of p53

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

The p53 protein family consists of three transcription factors: p53, p63, and p73. These proteins share significant structural and functional similarities and each has unique biological functions as well. Although the role of p53 in cellular stress is extensively studied, many questions remain about p63 and p73. In this review we summarize current data on functional interactions within the p53 family, their regulation and roles in response to genotoxic stress. We also discuss the significance of p73 and p63 for cancer therapy and outline novel approaches in development of therapeutic drugs that specifically target the p53 family.

Original languageEnglish (US)
Pages (from-to)152-163
Number of pages12
JournalDrug Resistance Updates
Volume11
Issue number4-5
DOIs
StatePublished - Aug 1 2008
Externally publishedYes

Fingerprint

DNA Damage
Proteins
Transcription Factors
Therapeutics
Pharmaceutical Preparations
Neoplasms

Keywords

  • Apoptosis
  • Drug resistance
  • E2F1
  • iASPP
  • RETRA
  • YAP1
  • ZEB1

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Cancer Research
  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Therapeutic prospects for p73 and p63 : Rising from the shadow of p53. / Vilgelm, Anna; El-Rifai, Wael; Zaika, Alexander.

In: Drug Resistance Updates, Vol. 11, No. 4-5, 01.08.2008, p. 152-163.

Research output: Contribution to journalArticle

@article{1eea0f0c548a441db6e593cb69c41791,
title = "Therapeutic prospects for p73 and p63: Rising from the shadow of p53",
abstract = "The p53 protein family consists of three transcription factors: p53, p63, and p73. These proteins share significant structural and functional similarities and each has unique biological functions as well. Although the role of p53 in cellular stress is extensively studied, many questions remain about p63 and p73. In this review we summarize current data on functional interactions within the p53 family, their regulation and roles in response to genotoxic stress. We also discuss the significance of p73 and p63 for cancer therapy and outline novel approaches in development of therapeutic drugs that specifically target the p53 family.",
keywords = "Apoptosis, Drug resistance, E2F1, iASPP, RETRA, YAP1, ZEB1",
author = "Anna Vilgelm and Wael El-Rifai and Alexander Zaika",
year = "2008",
month = "8",
day = "1",
doi = "10.1016/j.drup.2008.08.001",
language = "English (US)",
volume = "11",
pages = "152--163",
journal = "Drug Resistance Updates",
issn = "1368-7646",
publisher = "Churchill Livingstone",
number = "4-5",

}

TY - JOUR

T1 - Therapeutic prospects for p73 and p63

T2 - Rising from the shadow of p53

AU - Vilgelm, Anna

AU - El-Rifai, Wael

AU - Zaika, Alexander

PY - 2008/8/1

Y1 - 2008/8/1

N2 - The p53 protein family consists of three transcription factors: p53, p63, and p73. These proteins share significant structural and functional similarities and each has unique biological functions as well. Although the role of p53 in cellular stress is extensively studied, many questions remain about p63 and p73. In this review we summarize current data on functional interactions within the p53 family, their regulation and roles in response to genotoxic stress. We also discuss the significance of p73 and p63 for cancer therapy and outline novel approaches in development of therapeutic drugs that specifically target the p53 family.

AB - The p53 protein family consists of three transcription factors: p53, p63, and p73. These proteins share significant structural and functional similarities and each has unique biological functions as well. Although the role of p53 in cellular stress is extensively studied, many questions remain about p63 and p73. In this review we summarize current data on functional interactions within the p53 family, their regulation and roles in response to genotoxic stress. We also discuss the significance of p73 and p63 for cancer therapy and outline novel approaches in development of therapeutic drugs that specifically target the p53 family.

KW - Apoptosis

KW - Drug resistance

KW - E2F1

KW - iASPP

KW - RETRA

KW - YAP1

KW - ZEB1

UR - http://www.scopus.com/inward/record.url?scp=53049094623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53049094623&partnerID=8YFLogxK

U2 - 10.1016/j.drup.2008.08.001

DO - 10.1016/j.drup.2008.08.001

M3 - Article

C2 - 18801697

AN - SCOPUS:53049094623

VL - 11

SP - 152

EP - 163

JO - Drug Resistance Updates

JF - Drug Resistance Updates

SN - 1368-7646

IS - 4-5

ER -